| Year |
Citation |
Score |
| 2011 |
Marean A, Graf A, Zhang Y, Niswander L. Folic acid supplementation can adversely affect murine neural tube closure and embryonic survival. Human Molecular Genetics. 20: 3678-83. PMID 21693562 DOI: 10.1093/Hmg/Ddr289 |
0.313 |
|
| 2011 |
Peljto M, Marean A, Niswander L. The role of folic acid in regulating epigenetic processes during mammalian embryonic development Developmental Biology. 356: 223. DOI: 10.1016/J.Ydbio.2011.05.365 |
0.31 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2018 |
Olesnicky EC, Antonacci S, Popitsch N, Lybecker MC, Titus MB, Valadez R, Derkach PG, Marean A, Miller K, Mathai SK, Killian DJ. Shep interacts with posttranscriptional regulators to control dendrite morphogenesis in sensory neurons. Developmental Biology. PMID 30352216 DOI: 10.1016/J.Ydbio.2018.09.022 |
0.164 |
|
| 1978 |
Goldstein DP, Saracco P, Osathanondh R, Goldstein PR, Marean AR, Bernstein MR. Methotrexate with citrovorum factor rescue for gestational trophoblastic neoplasms. Obstetrics and Gynecology. 51: 93-6. PMID 201893 |
0.091 |
|
| 1976 |
Goldstein DP, Goldstein PR, Bottomley P, Osathanondh R, Marean AR. Methotrexate with citrovorum factor rescue for nonmetastatic gestational trophoblastic neoplasms. Obstetrics and Gynecology. 48: 321-3. PMID 181702 |
0.091 |
|
| 1980 |
Berkowitz RS, Desai U, Goldstein DP, Driscoll SG, Marean AR, Bernstein MR. Pretreatment curettage-A predictor of chemotherapy response in gestational trophoblastic neoplasia. Gynecologic Oncology. 10: 39-43. PMID 6249699 DOI: 10.1016/0090-8258(80)90060-8 |
0.087 |
|
| 1981 |
Berkowitz RS, Desai U, Goldstein DP, Driscoll SG, Marean AR, Bernstein MR. Pretreatment curettage—A predictor of chemotherapy response in gestational trophoblastic neoplasia Obstetrical and Gynecological Survey. 36: 48-49. |
0.087 |
|
| 1980 |
Federschneider JM, Goldstein DP, Berkowitz RS, Marean AR, Bernstein MR. Natural history of recurrent molar pregnancy. Obstetrics and Gynecology. 55: 457-9. PMID 7366903 |
0.049 |
|
| 1980 |
Berkowitz RS, Goldstein DP, Jones MA, Marean AR, Bernstein MR. Methotrexate with citrovorum factor rescue: reduced chemotherapy toxicity in the management of gestational trophoblastic neoplasms. Cancer. 45: 423-6. PMID 6243507 DOI: 10.1002/1097-0142(19800201)45:3<423::AID-CNCR2820450303>3.0.CO;2-G |
0.047 |
|
| 1982 |
Marean AR. The clinical nurse specialist's role in the management of gestational trophoblastic neoplasms. Major Problems in Obstetrics and Gynecology. 14: 229-41. PMID 6273661 |
0.045 |
|
| 1980 |
Berkowitz RS, Marean AR, Goldstein DP, Bernstein MR. Oral contraceptives and post-molar trophoblastic tumours. Lancet (London, England). 2: 752. PMID 6106866 DOI: 10.1016/S0140-6736(80)91979-0 |
0.045 |
|
| 1979 |
Berkowitz RS, Goldstein DP, Marean AR, Bernstein MR. Proliferative sequelae after evacuation of partial hydatidiform mole. Lancet (London, England). 2: 804-5. PMID 90910 DOI: 10.1016/S0140-6736(79)92167-6 |
0.028 |
|
| 1999 |
Aldous WK, Marean AJ, DeHart MJ, Matej LA, Moore KH. Effects of tamoxifen on telomerase activity in breast carcinoma cell lines. Cancer. 85: 1523-9. PMID 10193942 DOI: 10.1002/(SICI)1097-0142(19990401)85:7<1523::AID-CNCR13>3.0.CO;2-P |
0.025 |
|
| 2002 |
Aldous WK, Marean AJ, DeHart MJ, Moore KH. Fluorescent detection of telomerase activity. Methods in Molecular Biology (Clifton, N.J.). 191: 137-46. PMID 11951602 DOI: 10.1385/1-59259-189-2:137 |
0.01 |
|
| 1981 |
Berkowitz RS, Goldstein DP, Marean AR, Bernstein M. Oral contraceptives and postmolar trophoblastic disease. Obstetrics and Gynecology. 58: 474-7. PMID 6269038 |
0.01 |
|
| 1980 |
Berkowitz RS, Marean AR, Hamilton N, Bernstein M, Engle RP, Sandman G, Goldstein DP. Psychological and social impact of gestational trophoblastic neoplasia. The Journal of Reproductive Medicine. 25: 14-6. PMID 6249927 |
0.01 |
|
| 1980 |
Goldstein DP, Marean AR. Contraceptive counseling for teenagers Medical Aspects of Human Sexuality. 14: 23-24. |
0.01 |
|
| Hide low-probability matches. |